BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1640800)

  • 1. Chromogranin A correlates with norepinephrine release rate.
    Dimsdale JE; O'Connor DT; Ziegler M; Mills P
    Life Sci; 1992; 51(7):519-25. PubMed ID: 1640800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is physiologic sympathoadrenal catecholamine release exocytotic in humans?
    Takiyyuddin MA; Cervenka JH; Sullivan PA; Pandian MR; Parmer RJ; Barbosa JA; O'Connor DT
    Circulation; 1990 Jan; 81(1):185-95. PubMed ID: 2404624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympatho-adrenal secretion in humans: factors governing catecholamine and storage vesicle peptide co-release.
    Takiyyuddin MA; Brown MR; Dinh TQ; Cervenka JH; Braun SD; Parmer RJ; Kennedy B; O'Connor DT
    J Auton Pharmacol; 1994 Jun; 14(3):187-200. PubMed ID: 7929473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromogranin 'A' in normal subjects, essential hypertensives and adrenalectomized patients.
    Giampaolo B; Angelica M; Antonio S
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):41-50. PubMed ID: 12100068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating chromogranin A and catecholamines in human fetuses at uneventful birth.
    Moftaquir-Handaj A; Barbé F; Barbarino-Monnier P; Aunis D; Boutroy MJ
    Pediatr Res; 1995 Jan; 37(1):101-5. PubMed ID: 7700724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultradian variations of chromogranin A in humans.
    Takiyyuddin MA; Neumann HP; Cervenka JH; Kennedy B; Dinh TQ; Ziegler MG; Baron AD; O'Connor DT
    Am J Physiol; 1991 Oct; 261(4 Pt 2):R939-44. PubMed ID: 1681748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of region-specific immunoassay for human chromogranin A: substantial clue for detection and measurement of chromogranin A in human plasma.
    Yanaihara H; Hata M; Nishikawa Y; Hoshino M; Yanaihara N; Murai M
    Regul Pept; 1999 Mar; 80(1-2):83-90. PubMed ID: 10235638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The sympathetic nervous system activity estimated on serum concentration of chromogranin A in patients with the chronic heart failure].
    Rubinsztajn R
    Pol Arch Med Wewn; 2001 Mar; 105(3):217-24. PubMed ID: 11680266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma chromogranin A as a marker of sympathochromaffin activity in humans.
    Cryer PE; Wortsman J; Shah SD; Nowak RM; Deftos LJ
    Am J Physiol; 1991 Feb; 260(2 Pt 1):E243-6. PubMed ID: 1996627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does chromogranin a respond to short-term mild physiologic challenge?
    Dimsdale JE; O'Connor D; Ziegler M; Mills P
    Neuropsychopharmacology; 1989 Sep; 2(3):237-40. PubMed ID: 2789663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of chromogranin-A release from neuroendocrine sources in man: pharmacological studies.
    Takiyyuddin MA; Baron AD; Cervenka JH; Barbosa JA; Neumann HP; Parmer RJ; Sullivan PA; O'Connor DT
    J Clin Endocrinol Metab; 1991 Mar; 72(3):616-22. PubMed ID: 1671783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromogranin A: localization and stoichiometry in large dense core catecholamine storage vesicles from sympathetic nerve.
    O'Connor DT; Klein RL; Thureson-Klein AK; Barbosa JA
    Brain Res; 1991 Dec; 567(2):188-96. PubMed ID: 1817725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma chromogranin A in pheochromocytoma, primary hyperparathyroidism and pituitary adenoma in comparison with catecholamine, parathyroid hormone and pituitary hormones.
    Kimura N; Miura W; Noshiro T; Mizunashi K; Hanew K; Shimizu K; Watanabe T; Shibukawa S; Sohn HE; Abe K; Miura Y; Nagura H
    Endocr J; 1997 Apr; 44(2):319-27. PubMed ID: 9228469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours.
    Bernini GP; Moretti A; Ferdeghini M; Ricci S; Letizia C; D'Erasmo E; Argenio GF; Salvetti A
    Br J Cancer; 2001 Mar; 84(5):636-42. PubMed ID: 11237384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What do plasma and urinary measures of catecholamines tell us about human response to stressors?
    Dimsdale JE; Ziegler MG
    Circulation; 1991 Apr; 83(4 Suppl):II36-42. PubMed ID: 2009628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma chromogranin A: a marker of serotonin release and of emesis associated with cisplatin chemotherapy.
    Cubeddu LX; O'Connor DT; Parmer RJ
    J Clin Oncol; 1995 Mar; 13(3):681-7. PubMed ID: 7533826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma.
    Hsiao RJ; Parmer RJ; Takiyyuddin MA; O'Connor DT
    Medicine (Baltimore); 1991 Jan; 70(1):33-45. PubMed ID: 1988765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma chromogranin A marks emesis and serotonin release associated with dacarbazine and nitrogen mustard but not with cyclophosphamide-based chemotherapies.
    Cubeddu LX; O'Connor DT; Hoffmann I; Parmer RJ
    Br J Cancer; 1995 Oct; 72(4):1033-8. PubMed ID: 7547218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine sources of chromogranin-A in normal man: clues from selective stimulation of endocrine glands.
    Takiyyuddin MA; Cervenka JH; Pandian MR; Stuenkel CA; Neumann HP; O'Connor DT
    J Clin Endocrinol Metab; 1990 Aug; 71(2):360-9. PubMed ID: 2116438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and tissue chromogranin in patients with adrenocortical adenomas.
    Bernini GP; Moretti A; Borgioli M; Bardini M; Miccoli P; Berti P; Basolo F; Faviana P; Birindelli R; Salvetti A
    J Endocrinol Invest; 2004 Oct; 27(9):821-5. PubMed ID: 15648545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.